当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析

康泰生物

(300601)

  

流通市值:152.35亿  总市值:188.98亿
流通股本:9.00亿   总股本:11.17亿

康泰生物(300601)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.49亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益961051.52万元,未分配利润212402.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1413432.65万元,负债452381.13万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,063,443,044.891,392,061,330.52645,202,778.572,651,715,620.99
营业总成本1,925,316,368.31,293,245,266.49594,453,971.642,301,437,136.57
其他经营收益
营业利润5,892,770.881,725,506.2828,137,574.33181,224,375.2
利润总额202,302.43-121,922.0126,969,177.44149,936,979.79
净利润49,182,357.5837,600,910.4122,385,110.07201,553,722.8
每股收益
其他综合收益-93,372.99-95,966.13-56,881.31-90,939.67
综合收益总额49,088,984.5937,504,944.2822,328,228.76201,462,783.13
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计6,212,566,030.996,091,018,947.576,229,532,545.456,242,288,938.39
非流动资产:
非流动资产合计7,921,760,489.298,037,905,855.328,025,395,103.098,321,425,556.94
资产总计14,134,326,520.2814,128,924,802.8914,254,927,648.5414,563,714,495.33
流动负债:
流动负债合计2,300,430,568.072,287,083,688.212,327,486,213.632,647,146,164.79
非流动负债:
非流动负债合计2,223,380,772.982,242,918,295.632,244,047,248.682,255,542,981.53
负债合计4,523,811,341.054,530,001,983.844,571,533,462.314,902,689,146.32
所有者权益(或股东权益):
归属于母公司股东权益合计9,610,589,069.349,598,953,225.99,683,541,738.339,661,123,922.62
股东权益合计9,610,515,179.239,598,922,819.059,683,394,186.239,661,025,349.01
负债和股东权益合计14,134,326,520.2814,128,924,802.8914,254,927,648.5414,563,714,495.33
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,054,617,371.981,283,499,324.32581,746,831.932,933,618,620.58
经营活动现金流出小计1,692,154,072.251,207,902,571.92628,050,249.912,330,368,915.75
经营活动产生的现金流量净额362,463,299.7375,596,752.4-46,303,417.98603,249,704.83
投资活动产生的现金流量:
投资活动现金流入小计2,244,103,059.45867,721,438.3660,089,822.74862,894,399.8
投资活动现金流出小计1,570,315,399.79869,983,024.59125,315,698.651,419,581,999.18
投资活动产生的现金流量净额673,787,659.66-2,261,586.23-65,225,875.91-556,687,599.38
筹资活动产生的现金流量:
筹资活动现金流入小计51,665,606.1139,984,357.7825,584,357.78224,226,982.25
筹资活动现金流出小计381,933,620.34326,019,151.68124,526,138.31,024,984,900.02
筹资活动产生的现金流量净额-330,268,014.23-286,034,793.9-98,941,780.52-800,757,917.77
汇率变动对现金及现金等价物的影响-380,193.69-205,643.66-62,987.62-60,732.33
现金及现金等价物净增加额705,602,751.47-212,905,271.39-210,534,062.03-754,256,544.65
期末现金及现金等价物余额1,121,672,005.92203,163,983.06205,535,192.42416,069,254.45
补充资料:
现金及现金等价物的净增加额--212,905,271.39--754,256,544.65
最新报告期:2025-10-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中国银河程培0.110.380.462025-10-27
东海证券杜永宏0.180.330.502025-09-01
中信建投汤然,刘若飞,贺菊颖0.100.260.422025-08-25
华泰证券代雯,张云逸0.410.490.602025-08-24
中国银河程培0.270.370.462025-08-23
TOP↑